CK Health Plus

CK Health Plus is a healthcare and biotechnology company that operates as a subsidiary of CK Life Sciences Int'l., (Holdings) Inc., a member of the CK Hutchison Group. The company is primarily engaged in the development, marketing, and distribution of health supplements, nutraceuticals, and diagnostic products across the Asia-Pacific region. Through its parent company's research infrastructure, CK Health Plus is linked to advanced clinical-stage programs in oncology and pain management, including a Phase 3 melanoma vaccine. The company leverages a science-based approach to wellness, focusing on preventive health solutions and high-quality nutritional products. CK Health Plus plays a vital role in the commercialization strategy of the CK Life Sciences group, bridging the gap between laboratory innovation and consumer health markets.